rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Pluri Inc.

PLUR · Nasdaq

Health CareBiotechnologyNot moving yet

PLUR stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 60.8% below that average now. Biotechnology: 16% of its 561 stocks in an uptrend (−15 points in four weeks); Health Care: 26% (−10 points in four weeks).

SEC filings

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 52
Industry in uptrend
16% -15 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
16 (+5)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.

20 Apr – 19 Oct
17%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$6.3MNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders16+5 on the quarter
New · exited4 · 0
Reported value$55K

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
RENAISSANCE TECHNOLOGIES LLCreduced · filed 13 Aug 202618,324$38K-1,100−5.7%
MORGAN STANLEYreduced · filed 13 Aug 20262,982$6,232-94−3.1%
UBS Group AGadded · filed 13 Aug 20261,918$4,009+1,823+1918.9%
SIMA Wealth Partners, LLCunchanged · filed 28 Jul 2026350$73200.0%
CITIGROUP INCreduced · filed 3 Aug 2026191$393-1,169−86.0%
WELLS FARGO & COMPANYunchanged · filed 14 Aug 2026185$38600.0%
JPMORGAN CHASE & COnew · filed 12 Aug 2026125$269+125
SBI Securities Co., Ltd.unchanged · filed 23 Jul 202697$20300.0%
TD Waterhouse Canada Inc.added · filed 27 Jul 202695$198+2+2.2%
Activest Wealth Managementnew · filed 16 Jul 202686$177+86
31 Mar 2024 – 30 Jun 2026
21120Mar 24Sep 24Jun 25Dec 25Jun 26

News

No headline names it lately.

Everyone who traded it

Alexandre Weinstein Manieu Company insiderDirector, 10% owner · last 20 Aug 20261 · 0
Doron Shorrer Company insiderDirector · last 20 Aug 20263 · 1
Chutzpah Holdings Ltd Company insider10% owner · last 8 Dec 20251 · 0
Eitan Ajchenbaum Company insiderDirector · last 4 Dec 20250 · 0
Liat Zalts Company insiderChief Financial Officer · last 4 Dec 20250 · 0
Maital Shemesh-Rasmussen Company insiderDirector · last 4 Dec 20250 · 0
Rami Avraham Levi Company insiderDirector · last 4 Dec 20250 · 0
Yaky Yanay Company insiderChief Executive Officer · last 4 Dec 202511 · 7
Zami Aberman Company insiderDirector · last 4 Dec 202514 · 8
Pinhas Doron Birger Company insiderDirector · last 25 Feb 20250 · 0
Chen Franco-Yehuda Company insiderChief Financial Officer · last 18 Sep 20240 · 0
Lorne Kenneth Abony Company insiderDirector · last 23 Jan 20240 · 0

Same industry

MRNA ModernaLeading+154%
IOVA Iovance BiotherapeuticsLeading+133%
ABCL AbCellera BiologicsLeading+61%
ENTX Entera BioLeading+49%
HALO Halozyme TherapeuticsLeading+46%
XERS Xeris Biopharma HoldingsLeading+46%
HELP Helus PharmaLeading+37%
XNCR XencorLeading+32%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2026 · to 30 Jun 202644.6%
Share count trendFY 2026 · to 9 Sep 202614.0%
Cash and equivalentsFY 2026 · to 30 Jun 2026$3.5M
Free cash flowFY 2026 · to 30 Jun 2026−$20.2M

Analyst forecasts

No analyst forecasts yet.